VCBeat Health Contact Us
Home ABOGEN Biosciences Appoints Ms. Yan Zhang as Chief Financial Officer

ABOGEN Biosciences Appoints Ms. Yan Zhang as Chief Financial Officer

Jul 15, 2021 14:04 CST Updated 14:04
Abogen

Nucleic Acid Drug Developer

On July 14, Abogen announced that Ms. Zhang Yan has officially joined the company as Chief Financial Officer. Abogen is an innovative biopharmaceutical company focused on the research and development of messenger RNA (mRNA) therapeutics.

*Disclaimer: This article was written by a contributing author to Sina Medical News. The views expressed are solely those of the author and do not necessarily reflect the position of Sina Medical News.